SCHEMBL20249793

SCHEMBL20249793

N=C(N)/C=C\Nc1cccc(F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.54
RAB9A P51151 4/20 0.54
MAPT P10636 4/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
NFKB1 P19838 2/20 0.54
NFKB2 Q00653 2/20 0.54
RELA Q04206 2/20 0.54
TP53 P04637 2/20 0.48
CASP1 P29466 2/20 0.48
HSD17B10 Q99714 2/20 0.48
IDO1 P14902 1/20 0.44
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
TSHR P16473 2/20 0.41
MAPK10 P53779 1/20 0.41
KCNH2 Q12809 1/20 0.41
MMP2 P08253 4/20 0.41
MMP1 P03956 3/20 0.41
MMP9 P14780 3/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19192553 0.80 RAB9A (0.49) NPC1RAB9AMAPTSMN1; SMN2NFKB1
SCHEMBL19492784 0.80 NPC1 (0.53) NPC1RAB9AMAPTSMN1; SMN2NFKB1
SCHEMBL20249842 0.79 MAPT (0.47) NPC1RAB9AMAPTSMN1; SMN2NFKB1
SCHEMBL20249819 0.79 MEN1 (0.67) NPC1RAB9AMAPTSMN1; SMN2IDO1
SCHEMBL25711639 0.77 RAB9A (0.54) NPC1RAB9AMAPTSMN1; SMN2NFKB1
SCHEMBL20249697 0.77 NPC1 (0.33) NPC1RAB9AMAPTSMN1; SMN2NFKB1
SCHEMBL20249838 0.75 SMN1; SMN2 (0.39) NPC1RAB9AMAPTSMN1; SMN2NFKB1
SCHEMBL19657932 0.74 NPC1 (0.71) NPC1RAB9AMAPTSMN1; SMN2NFKB1
SCHEMBL3443268 0.74 IDO1 (0.58) NPC1RAB9AMAPTIDO1MEN1
SCHEMBL20250034 0.73 NPC1 (0.59) NPC1RAB9AMAPTSMN1; SMN2NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018107056-A1 1,3-SUBSTITUED PYRAZOLE COMPOUNDS USEFUL FOR REDUCTION OF VERY LONG CHAIN FATTY ACIC LEVELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-06-14 WO disclosed